future market growth

Industry Trend Analysis: The  Influenza Diagnostics Market  was worth USD 0.42 billion in 2014 and is expected to reach approximately USD 0.88 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.45% during the forecast period. Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza. Competitive Insights: The leading players in the market are Roche Diagnostics, Meridian Bioscience Inc., Becton, Abbott, QIAGEN, Alere Inc., Thermo Fisher Scientific Inc., and Dickinson & Company. The Influenza Diagnostics Market is segmented as follows- By Natural Test Type: Traditional Viral Culture Serology Test Rapid Influenza Detection Test DFA By Molecular Test Type: Nucleic Acid Sequence-Based Amplification (NASBA) RT-PCR Loop-Mediated Isothermal Amplification-Based Assays (LAMP) Simple Amplification-Based Assays (SAMBA) By End User: Hospital Clinic Reference lab...

Industry Trend Analysis: The Influenza Diagnostics Market was worth USD 0.42 billion in 2014 and is expected to reach approximately USD 0.88 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.45% during the forecast period. Browse Full Report @ https://www.crystalmarketresearch.com/report/influenza-diagnostics-market . Influenza or popularly known as ‘Flu’ is an infectious disease that is caused by any virus of influenza. Test Type Outlook and Trend Analysis: According to the Type the market of Influenza Diagnostics is divided into Traditional and Molecular. Rapid Influenza Detection Test (RIDT) constituted the major share of the market due to its benefits such as quick results, user friendly, etc. The RIDT is expected to continue growing during the forecast period. The Molecular test types segment is also further divided into Nucleic Acid Sequence-Based Amplification (NASBA), RT-PCR, Loop-Mediated Isothermal Amplification-Based ...